Caxton Associates (UK)’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Caxton Associates (UK)'s ALAB Position: Q2 2026 in Review
Caxton Associates (UK) opened a new position in Astera Labs (ALAB) in Q2 2026: 3,554 shares worth $1.72M. The stake represents 0.03% of the portfolio and ranks #295 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in ALAB as recently as Q4 2025.
Caxton Associates (UK) first reported a position in ALAB in Q2 2025 and has held it in 3 quarters since. The position peaked at $14.8M in Q2 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Caxton Associates (UK) held 3,554 shares of Astera Labs worth $1.72M as of Q2 2026.
- Astera Labs was a new Caxton Associates (UK) position in Q2 2026.
- Astera Labs made up 0.03% of Caxton Associates (UK)'s portfolio in Q2 2026, its #295 holding.
- Caxton Associates (UK) first reported a position in Astera Labs in Q2 2025 and has held it in 3 quarters since.
- Caxton Associates (UK)'s Astera Labs position peaked at $14.8M in Q2 2025.
- 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.